Product Images Risedronate Sodium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Risedronate Sodium NDC 68382-075 by Zydus Pharmaceuticals Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
structural formula image 01 - dbaf72d0 4637 48c7 90f8 5746db051e1f 01
figure - dbaf72d0 4637 48c7 90f8 5746db051e1f 02
Risedronate Sodium DR Tablets, 35 mg - dbaf72d0 4637 48c7 90f8 5746db051e1f 03
This text appears to be a combination of different information sources and is not coherent enough to generate a useful description. Therefore, it is not available.*
Risedronate Sodium DR Tablets, 35 mg - dbaf72d0 4637 48c7 90f8 5746db051e1f 04
Risedronate Sodium DR Tablets, 35 mg - dbaf72d0 4637 48c7 90f8 5746db051e1f 05
This is a set of instructions for taking Risedronate Sodium Delayed-release tablets, which contain 35 mg of isedronate sodium USP. The tablets should be taken once a week after breakfast with plain water, and should not be chewed or crushed. The patient should remain upright for at least 30 minutes after taking the tablet and should not take calcium, magnesium-based supplements, antacids or iron preparations at the same time of the day. Packaging instructions should be followed. The product should be stored in a controlled room temperature and kept out of reach of children. The manufacturer is Cadila Healthcare Ltd, distributed by Zydus Pharmaceuticals. All information can be found in the enclosed medication guide.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.